Haring-Layton MarDee 4
4 · Dare Bioscience, Inc. · Filed Sep 4, 2025
Insider Transaction Report
Form 4
Haring-Layton MarDee
Chief Accounting Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-09-04+57,000→ 57,000 totalExercise: $2.13Exp: 2035-09-04→ Common stock (57,000 underlying)
Footnotes (1)
- [F1]This stock option was granted to the reporting person as a retention award and vests and becomes exercisable on 9/4/2027, provided, that, if certain performance criteria are satisfied, it will vest and become exercisable on the date such performance criteria are satisfied, subject to the reporting person's continuous service to the issuer.